Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic interaction of test formulations
of candesartan and felodipine in a combination package comparing with the fasting intake of
commercial formulations of both Atacand ® and Splendil®
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborators:
Clínica São Lucas, Hospital Sírio Libanês de Itatiba S/C Cori Analyticals Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Centro de Bioequivalência Faculty of Pharmaceutical Sciences of Ribeirão Preto - Bioequivalence Center LabClin Laboratório Clínico Laboratório de Patologia Clínica Dr. Franceschi Ltda. Scentryphar Clinical Research